Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel M Meier-Menches

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Molecular Therapy. Nucleic Acids|January 16, 2026
Beyond the stop: Oxadiazole TRIDs restore LRBA protein expression in nonsense-driven primary immunodeficiencyIgnazio Fiduccia, Emanuele Vitale, Riccardo Varrica, et al.
Molecular & Cellular Proteomics : MCP|December 3, 2017
Proteomics and metabolomics identify molecular mechanisms of aging potentially predisposing for chronic lymphocytic leukemiaRupert L Mayer, Josef D Schwarzmeier, Marlene C Gerner, et al.
Pharmaceutics|February 26, 2022
The Anticancer Ruthenium Compound BOLD-100 Targets Glycolysis and Generates a Metabolic Vulnerability towards Glucose DeprivationDina Baier, Beatrix Schoenhacker-Alte, Mate Rusz, et al.
Inorganic Chemistry|February 15, 2018
Rollover Cyclometalated Bipyridine Platinum Complexes as Potent Anticancer Agents: Impact of the Ancillary Ligands on the Mode of ActionMaria V Babak, Martin Pfaffeneder-Kmen, Samuel M Meier-Menches, et al.
Journal of Medicinal Chemistry|January 27, 2026
Structure-Activity Relationships of Silver(I)- and Gold(I)-NHC Complexes Reveal Distinctly Different Responses of Cisplatin-Resistant Ovarian Cancer to Bis-NHC-Gold(I) DerivativesJulia H Bormio Nunes, Christina Hacker, Monika Caban, et al.
Iscience|December 12, 2022
A multi-omics based anti-inflammatory immune signature characterizes long COVID-19 syndromeJohannes J Kovarik, Andrea Bileck, Gerhard Hagn, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 27, 2023
The Lipid Metabolism as Target and Modulator of BOLD-100 Anticancer Activity: Crosstalk with Histone AcetylationDina Baier, Theresa Mendrina, Beatrix Schoenhacker-Alte, et al.
Angewandte Chemie (International Ed. in English)|March 23, 2021
Interfering with Metabolic Profile of Triple-Negative Breast Cancers Using Rationally Designed Metformin ProdrugsMaria V Babak, Kai Ren Chong, Peter Rapta, et al.
International Journal of Cancer|February 18, 2020
Lipid droplet-mediated scavenging as novel intrinsic and adaptive resistance factor against the multikinase inhibitor ponatinibBernhard Englinger, Anna Laemmerer, Patrick Moser, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|October 12, 2022
Highly Cytotoxic Molybdenocenes with Strong Metabolic Effects Inhibit Tumour Growth in MiceValentin Fuchs, Klaudia Cseh, Michaela Hejl, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Molecular Therapy. Nucleic Acids|January 16, 2026
Beyond the stop: Oxadiazole TRIDs restore LRBA protein expression in nonsense-driven primary immunodeficiencyIgnazio Fiduccia, Emanuele Vitale, Riccardo Varrica, et al.
Molecular & Cellular Proteomics : MCP|December 3, 2017
Proteomics and metabolomics identify molecular mechanisms of aging potentially predisposing for chronic lymphocytic leukemiaRupert L Mayer, Josef D Schwarzmeier, Marlene C Gerner, et al.
Pharmaceutics|February 26, 2022
The Anticancer Ruthenium Compound BOLD-100 Targets Glycolysis and Generates a Metabolic Vulnerability towards Glucose DeprivationDina Baier, Beatrix Schoenhacker-Alte, Mate Rusz, et al.
Inorganic Chemistry|February 15, 2018
Rollover Cyclometalated Bipyridine Platinum Complexes as Potent Anticancer Agents: Impact of the Ancillary Ligands on the Mode of ActionMaria V Babak, Martin Pfaffeneder-Kmen, Samuel M Meier-Menches, et al.
Journal of Medicinal Chemistry|January 27, 2026
Structure-Activity Relationships of Silver(I)- and Gold(I)-NHC Complexes Reveal Distinctly Different Responses of Cisplatin-Resistant Ovarian Cancer to Bis-NHC-Gold(I) DerivativesJulia H Bormio Nunes, Christina Hacker, Monika Caban, et al.
Iscience|December 12, 2022
A multi-omics based anti-inflammatory immune signature characterizes long COVID-19 syndromeJohannes J Kovarik, Andrea Bileck, Gerhard Hagn, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 27, 2023
The Lipid Metabolism as Target and Modulator of BOLD-100 Anticancer Activity: Crosstalk with Histone AcetylationDina Baier, Theresa Mendrina, Beatrix Schoenhacker-Alte, et al.
Angewandte Chemie (International Ed. in English)|March 23, 2021
Interfering with Metabolic Profile of Triple-Negative Breast Cancers Using Rationally Designed Metformin ProdrugsMaria V Babak, Kai Ren Chong, Peter Rapta, et al.
International Journal of Cancer|February 18, 2020
Lipid droplet-mediated scavenging as novel intrinsic and adaptive resistance factor against the multikinase inhibitor ponatinibBernhard Englinger, Anna Laemmerer, Patrick Moser, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|October 12, 2022
Highly Cytotoxic Molybdenocenes with Strong Metabolic Effects Inhibit Tumour Growth in MiceValentin Fuchs, Klaudia Cseh, Michaela Hejl, et al.
Pageof 6